Wasting

Wasting is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

Coronavirus COVID-19 (SARS-CoV-2)Coronavirus COVID-19 (SARS-CoV-2)

COVID-19 December 2020 Update: Therapies and VaccinesCOVID-19 December 2020 Update: Therapies and Vaccines

Moderna COVID-19 VaccineModerna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19Managing Stress and Coping with COVID-19

Managing Sleep Problems during COVID-19Managing Sleep Problems during COVID-19

-- The first section of this topic is shown below --

CLINICAL

  • Wasting: Unintentional weight loss >10%; may also be defined by unintentional weight loss >5% over 3 months or a BMI < 18.5.
  • Wasting syndrome: Unintentional weight loss >10% plus diarrhea or chronic weakness and documented fever for ≥30 days.
  • Wasting syndrome is an AIDS-defining condition (category C); wasting is evidence of symptomatic HIV infection (category B).
  • Seen during critical illness and hospitalization, may prolong convalescence.
  • Likely multifactorial related to a proinflammatory state (with potential associated anorexia), hypogonadism, and malabsorption.
  • Must be differentiated from lipoatrophy, which is isolated fat loss (see Lipodystrophy). Wasting/weight loss is consequence of AIDS disease progression and OIs, while lipoatrophy often seen in pts on some less-used ART regimens.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

CLINICAL

  • Wasting: Unintentional weight loss >10%; may also be defined by unintentional weight loss >5% over 3 months or a BMI < 18.5.
  • Wasting syndrome: Unintentional weight loss >10% plus diarrhea or chronic weakness and documented fever for ≥30 days.
  • Wasting syndrome is an AIDS-defining condition (category C); wasting is evidence of symptomatic HIV infection (category B).
  • Seen during critical illness and hospitalization, may prolong convalescence.
  • Likely multifactorial related to a proinflammatory state (with potential associated anorexia), hypogonadism, and malabsorption.
  • Must be differentiated from lipoatrophy, which is isolated fat loss (see Lipodystrophy). Wasting/weight loss is consequence of AIDS disease progression and OIs, while lipoatrophy often seen in pts on some less-used ART regimens.

There's more to see -- the rest of this entry is available only to subscribers.